Elixirr International (ELIX) H2 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 TU earnings summary
22 Jan, 2026Executive summary
FY 25 revenue expected to meet or exceed £149 million, reflecting strong momentum and record cross-sell revenue.
Adjusted EBITDA margin anticipated at 28.1%–29.2%, supported by operating leverage and disciplined cost control.
Number of 'gold clients' (over £1m annual revenue) increased to 34 from 27 year-over-year.
Consistent delivery against the Rule of 40 and Rule of 50, supporting ambitions to enter the FTSE 250 within 12 months.
Entered FY 26 with a record amount of contracted revenue.
Financial highlights
FY 25 revenue expected to meet or exceed £149 million, in line with or above market expectations.
Adjusted EBITDA margin projected at 28.1%–29.2%.
Year-end net debt at £24.1 million, approximately £7 million better than market expectations.
Interim dividend of 7.6p per share declared, up 21% from FY 24, totaling approximately £3.8 million.
Outlook and guidance
Board aims for FTSE 250 entry within the next 12 months, citing consistent high performance.
Active acquisition pipeline with continued focus on value-accretive deals and disciplined capital allocation.
FY 26 started with record contracted revenue.
Latest events from Elixirr International
- Record H1 2024 revenue and EBITDA growth, strong cash flow, and positive FY24 outlook.ELIX
H1 202419 Jan 2026 - Record FY24 growth, US expansion, and Main Market move set stage for continued outperformance.ELIX
H2 20247 Jan 2026 - 35% revenue and 42% EBITDA growth, Main Market move, and TRC deal drive strong outlook.ELIX
H1 202521 Dec 2025 - FY24 results beat expectations, with strong growth, high margins, and full debt repayment.ELIX
H2 2024 TU8 Oct 2025 - Record revenue growth and strong margins in H1 2025, with a confident outlook for FY 2025.ELIX
H1 2025 TU8 Oct 2025